Key Moments
The Science & Treatment of Obsessive Compulsive Disorder (OCD)
Andrew HubermanKey Moments
OCD is a debilitating condition characterized by intrusive obsessions and compulsive actions, driven by anxiety and a disrupted cortico-striatal-thalamic loop. Effective treatments include CBT, SSRIs, and emerging brain stimulation methods, often best used in combination.
Key Insights
OCD is a severe and common debilitating illness (ranked #7 globally) characterized by intrusive, recurrent obsessions and compulsions that provide only brief relief and actually strengthen the obsession and anxiety over time.
Obsessive-Compulsive Personality Disorder (OCPD) is distinct from OCD; OCPD involves a desire for order and delayed gratification, which can be adaptive, whereas OCD's obsessions are unwanted and debilitating.
The core brain circuit implicated in OCD is the corticostriatal-thalamic loop, which involves perception (cortex), action selection/suppression (striatum), and sensory/thought gating (thalamus, thalamic reticular nucleus).
Cognitive Behavioral Therapy (CBT), specifically exposure and response prevention, is highly effective for many OCD patients. It requires progressive exposure to anxiety-provoking triggers and preventing compulsive rituals, often involving 'homework' and sometimes home visits.
SSRIs (Selective Serotonin Reuptake Inhibitors) are also effective in reducing OCD symptoms, although less so than CBT alone. Combining SSRIs with CBT from the outset doesn't show additional benefit, but adding CBT to existing SSRI treatment further improves symptoms.
New and emerging treatments like ketamine, psilocybin, and transcranial magnetic stimulation (TMS) are being explored for OCD, with varying degrees of promise. Cannabis and CBD have, so far, shown little acute impact on OCD symptoms.
DISTINGUISHING OCD FROM OBSESSIVE-COMPULSIVE PERSONALITY DISORDER (OCPD)
Obsessive-Compulsive Disorder (OCD) is a severe and debilitating condition, ranking seventh among all illnesses globally due to the immense suffering it causes. It is characterized by intrusive, unpleasant thoughts (obsessions) and repetitive behaviors (compulsions) designed to alleviate the anxiety caused by these thoughts. Crucially, engaging in compulsions offers only temporary relief, ultimately reinforcing and strengthening the obsessions. This is distinct from Obsessive-Compulsive Personality Disorder (OCPD), where individuals desire order and perfection, often finding it enjoyable and enabling better functioning, without the intrusive, unwelcome nature of OCD's obsessions.
THE DEBILITATING NATURE OF OCD
OCD significantly impairs quality of life, leading to substantial struggles in work, relationships, and daily activities. The constant intrusive thoughts and time-consuming compulsions consume hours, days, and even years, diverting focus from other functional aspects of life. Shame and secrecy surrounding the disorder often prevent individuals from seeking diagnosis and treatment, further exacerbating their suffering. The pervasive nature of OCD means obsessions and compulsions can manifest across all domains of an individual's life, making it impossible to escape the relentless cycle of anxiety and ritualistic behavior.
CATEGORIES OF OBSESSIONS AND COMPULSIONS
OCD commonly presents in three categories: checking, repetition, and order. Checking compulsions involve repeatedly verifying actions like locking doors or turning off stoves. Repetition involves actions such as counting or performing specific movements a set number of times. Order obsessions encompass a need for symmetry, alignment, cleanliness (often linked to contamination fears), or a feeling of incompleteness. These compulsions, while providing fleeting relief, only intensify the underlying anxiety and the intrusive thoughts, trapping individuals in a continuous cycle.
ANXIETY: THE BINDING FORCE OF OCD
Anxiety serves as the critical link between obsessions and compulsions. Unlike fear, which responds to an immediate threat, anxiety in OCD is a heightened state of autonomic arousal (increased heart rate, breathing, narrowed vision) in the absence of a clear external danger, triggered by intrusive thoughts. Individuals with OCD perform compulsions to temporarily alleviate this intense anxiety, even when they recognize the irrationality of their actions. This relief, however brief, reinforces the compulsion, making the obsession stronger over time and deepening the anxiety, creating a vicious cycle. OCD is often co-morbid with depression and other anxiety disorders.
GENETIC INFLUENCES ON OCD
Approximately 40-50% of OCD cases have a genetic component, indicating a predisposition that can manifest through mutations or inherited aspects. While genetics play a role, their exact mechanisms are not fully understood, and current therapeutic approaches primarily focus on behavioral and pharmacological interventions rather than direct genetic modulation. Understanding this genetic link helps contextualize the disorder's origins but largely remains outside the scope of direct therapeutic control for most individuals at present.
THE CORTICO-STRIATAL-THALAMIC LOOP: OCD'S NEURAL CIRCUITRY
OCD is underpinned by a dysfunctional cortico-striatal-thalamic loop in the brain. The cortex is responsible for perception and understanding. The striatum and basal ganglia control action selection ("go") and inhibition ("no-go"). The thalamus relays sensory information, gated by the thalamic reticular nucleus, which filters what reaches conscious awareness. In OCD, this loop is overactive, leading to the recurrent, intrusive thoughts and compulsive behaviors. Studies show increased activity in this loop during obsessions and compulsions, which decreases with effective treatments, highlighting its central role in the disorder.
EXPERIMENTAL EVIDENCE OF OCD'S NEURAL BASIS
Research using neuroimaging (fMRI, PET scans) on human subjects has consistently shown hyperactivity in the cortico-striatal-thalamic loop when individuals with OCD experience obsessions and compulsions. Furthermore, studies in animal models, employing optogenetics to stimulate this circuit, have successfully induced OCD-like behaviors, such as incessant grooming, in previously healthy animals. These findings provide strong causal evidence, reinforcing the notion that this specific neural circuit is fundamental to the generation and perpetuation of OCD symptoms. Effective pharmacological and behavioral interventions also demonstrate reduced activity in this loop.
DIAGNOSING OCD: THE YALE-BROWN OBSESSIVE COMPULSIVE SCALE (Y-BOCS)
Diagnosis of OCD typically involves the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), a comprehensive assessment that defines and categorizes obsessions (unwelcome, distressing, recurrent thoughts, images, or impulses) and compulsions (driven behaviors or acts to alleviate anxiety). The scale probes various categories of obsessions (e.g., aggressive, contamination, sexual, saving, moral, symmetry) and helps clinicians identify the specific fears underlying these symptoms. Precise identification of these core fears is crucial for tailoring effective treatments and disrupting the reinforcing loop of anxiety and compulsion.
COGNITIVE BEHAVIORAL THERAPY (CBT) AND EXPOSURE THERAPY FOR OCD
CBT, particularly Exposure and Response Prevention (ERP), is a highly effective treatment for OCD. Unlike CBT for other anxiety disorders, the goal in OCD is to help patients tolerate, rather than immediately relieve, their anxiety. This involves gradually exposing patients to their most feared triggers (staircasing) and actively preventing them from engaging in their habitual compulsions. This progressive exposure teaches patients that anxiety can exist without catastrophic outcomes and that the compulsive rituals are not necessary. This interruption of the thought-action loop is vital for long-term symptom relief.
UNIQUE ASPECTS OF OCD TREATMENT: HOMEWORK AND HOME VISITS
CBT for OCD incorporates unique elements like 'homework' and, in some cases, home visits by clinicians. Homework assignments involve practicing exposure and response prevention in daily life, outside the supportive clinical environment, to generalize learning and prevent relapse. Home visits are critical because an individual's home environment can act as a "conditioned place," triggering ingrained obsessions and compulsions. Clinicians can observe these patterns directly, identify subtle avoidant behaviors, and provide tailored interventions to help patients confront their anxiety in real-world settings, thereby breaking context-dependent cycles.
EFFECTIVENESS OF SSRIS AND COMBINATION THERAPIES
Selective Serotonin Reuptake Inhibitors (SSRIs) are a primary pharmacological treatment for OCD, working by increasing serotonin availability in synapses. While effective in reducing symptoms more than placebo, SSRIs are often less potent than CBT alone. Studies show that combining SSRIs with CBT from the outset may not offer additional benefits beyond CBT alone. However, for patients already on SSRIs, adding CBT can significantly further reduce OCD symptoms. This highlights the importance of individualized treatment plans, often involving a combination of therapies under close medical supervision, as SSRIs can have various side effects and individual responses differ.
NEUROCHEMICAL MYSTERIES AND EMERGING TREATMENTS
Despite SSRIs' effectiveness, there's little direct evidence of serotonin system disruption as the cause of OCD. This mirrors a broader theme in psychiatry where effective drugs don't always target the root cause. This complexity fuels exploration into other neurochemical systems and new treatments. Beyond SSRIs, neuroleptics (targeting dopamine/glutamate) are sometimes used. Research also explores psychedelics like psilocybin and ketamine, and non-invasive brain stimulation like transcranial magnetic stimulation (TMS). So far, efficacy for these newer treatments in OCD is promising but still under investigation, and cannabis/CBD have shown limited acute impact on OCD symptoms.
THE POWER OF "THOUGHTS ARE NOT ACTIONS"
A crucial therapeutic insight for OCD patients is to understand that "thoughts are not actions." Many individuals with OCD equate intrusive, disturbing, or taboo thoughts with the actual performance of harmful actions. This cognitive distortion fuels intense anxiety and compulsive behaviors aimed at suppressing these thoughts. By patiently guiding patients to recognize that thoughts are merely neural predictions and often arise spontaneously without implying malicious intent, clinicians can help reduce the internal pressure to engage in compulsions. This paradigm shift enables patients to tolerate thoughts and associated anxiety, weakening the obsession-compulsion cycle.
HORMONAL INFLUENCES ON OCD
Emerging research suggests a link between hormonal imbalances and OCD symptoms. Studies show elevated cortisol (a stress hormone) and DHEA in females with OCD, and increased cortisol with reduced testosterone in males with OCD. These hormonal shifts appear to alter the brain's GABAergic system, which normally dampens neural activity. A reduction in GABA transmission could lead to increased excitation in brain networks, potentially affecting the cortico-striatal-thalamic loop. This opens new avenues for exploring hormone-based therapies, especially given the correlation between OCD onset and puberty, and the availability of generic hormone-modulating drugs.
HOLISTIC AND NEUTRACEUTICAL APPROACHES
While traditional treatments are primary, some holistic methods and nutraceuticals are being explored. Mindfulness meditation, for instance, can enhance focus, indirectly supporting CBT by helping patients concentrate on therapeutic tasks rather than obsessions. Nutraceuticals like 5-HTP, tryptophan (serotonin precursors), and inositol have shown some promise in reducing OCD symptoms in studies, with inositol demonstrating anxiolytic effects at high doses. However, these require careful, systematic exploration in combination with behavioral and pharmacological interventions, and their individual efficacy can vary, underscoring the need for further research.
Mentioned in This Episode
●Supplements
●Products
●Software & Apps
●Companies
●Organizations
●Books
●Drugs & Medications
●Studies Cited
●People Referenced
Common Questions
OCD is characterized by intrusive, unwanted obsessions and compulsive behaviors that provide only brief relief and then strengthen the obsession. OCPD, however, lacks the intrusive aspect; individuals with OCPD often welcome their meticulous thought patterns as they help them function better, though both can be debilitating.
Topics
Mentioned in this video
Host of the Huberman Lab podcast and a professor of neurobiology and ophthalmology at Stanford School of Medicine.
A world-class researcher at Johns Hopkins School of Medicine studying the use of psychedelics for depression and other psychiatric challenges.
A psychiatrist at Stanford exploring TMS in combination with psychedelic therapies.
A clinician scientist (MD, PhD) from Yale University School of Medicine and author of a thorough review on pharmacotherapeutic strategies and new targets in OCD.
A band member of The Ramones, who was known to have OCD and exhibited compulsive behaviors like walking up and down stairs a certain number of times.
An MD and PhD research scientist and clinician at Columbia University School of Medicine, a foremost expert on OCD mechanisms and treatments.
A researcher at Harvard who studies motor sequences and motor learning, and whose work on superstitions in animals and humans is admired.
A medical doctor and psychiatrist with whom Andrew Huberman discussed cannabis and its clinical applications.
A supplement company partnered with Huberman Lab podcast known for high-quality supplements that ship internationally, where all supplements discussed on the podcast can be found.
An all-in-one vitamin, mineral, and probiotic drink with adaptogens and digestive enzymes, recommended by Andrew Huberman for foundational nutritional needs.
A smart mattress cover that provides cooling, heating, and sleep tracking, used by Andrew Huberman to improve sleep consistency.
A brain-machine interface company that Andrew Huberman believes will likely focus on treating movement and psychiatric syndromes before cognitive enhancement.
A vitamin that, along with K2, supports numerous factors in brain and body health, often supplemented with Athletic Greens.
A component of Andrew Huberman's sleep toolkit.
An amino acid that acts as an inhibitory neurotransmitter, explored at very high dosages in some studies for various effects.
A hormone found to be elevated in females with OCD, known to be a potent antagonist of the Gaba system.
An inhibitory neurotransmitter associated with lower anxiety levels and neural circuit balance, which appears to be reduced in OCD patients due to hormonal influences.
A supplement in the serotonin pathway that has shown effects in improving or reducing OCD symptoms, similar to SSRIs.
A component of Andrew Huberman's sleep toolkit.
A supplement in the serotonin pathway that has shown effects in improving or reducing OCD symptoms, similar to SSRIs.
A component of Andrew Huberman's sleep toolkit.
A vitamin that, along with D3, supports numerous factors in brain and body health, often supplemented with Athletic Greens.
A compound with impressive effects on reducing anxiety, improving fertility, and enhancing sleep, explored for OCD treatment at very high dosages.
A study published in the American Journal of Psychiatry that compared the effectiveness of CBT, SSRIs, and their combination for OCD treatment.
The first placebo-controlled investigation of cannabis in adults with OCD, co-authored by Dr. Helen Blair Simpson, which found little acute impact on OCD symptoms and smaller anxiety reductions compared to placebo.
A study that explored serum neurosteroid levels in OCD patients, revealing elevated cortisol and DHEA in females and elevated cortisol with reduced testosterone in males, suggesting altered GABA transmission.
A study by first author Pinto that found OCPD subjects showed an excessive capacity to delay reward compared to OCD subjects, distinguishing the two disorders.
A classic psychological experiment performed on young children to assess their ability to delay gratification, where waiting for a period earns a second marshmallow.
A review from 2011 discussing various supplements including 5-HTP, tryptophan, and inositol, and their potential in OCD treatment.
A foundational paper describing protocols for cognitive behavioral therapy and exposure therapy for OCD.
A comprehensive review by Christopher Pittenger from 2021 that discusses drug treatments and potential new targets for OCD, noting the lack of direct evidence for serotonin system disruption.
A class selective serotonin reuptake inhibitor (SSRI) used in OCD treatment, sometimes in children.
A legal prescription drug (in the US) that acts on the glutamate system, being explored for trauma, depression, and OCD, showing some promising but not overwhelming results for OCD.
A classic selective serotonin reuptake inhibitor (SSRI) used in OCD treatment.
A psychedelic drug being explored for the treatment of depression and OCD, targeting serotonin 2A and 1A receptors, though effectiveness for OCD is currently inconclusive.
A neuroleptic drug that reduces dopamine transmission, often used in conjunction with SSRIs for OCD.
A classic selective serotonin reuptake inhibitor (SSRI) used in OCD treatment.
A classic selective serotonin reuptake inhibitor (SSRI) used in OCD treatment.
A selective serotonin reuptake inhibitor (SSRI) that is used in children and available in pediatric doses.
An institution where clinical trials on psilocybin for depression have been conducted by Matthew Johnson.
A US government body that has launched a 'Division of Complementary Health' to explore non-traditional treatments like meditation.
The institution where Benoit L. studies motor sequences and motor learning.
The institution where Andrew Huberman is a professor and where some of the referenced research is conducted.
More from Andrew Huberman
View all 342 summaries
40 minBenefits of Sauna & Deliberate Heat Exposure | Huberman Lab Essentials
148 minAvoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
31 minEssentials: The Biology of Taste Perception & Sugar Craving | Dr. Charles Zuker
189 minUnlearn Negative Thoughts & Behaviors Patterns | Dr. Alok Kanojia (Healthy Gamer)
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free